Gitelman Syndrome in a Toddler With Normal Blood Test Findings Except on Sick Days

Shoichiro Shirane1, Shogo Amemiya1, Yuya Saito1

  • 1Department of Pediatrics, Tokyo Metropolitan Tama-Hokubu Medical Center, Tokyo, Japan.

PubMed

Insights

Gitelman syndrome (GS) can present with electrolyte and acid-base abnormalities, particularly during illness. This case highlights the importance of considering GS in patients with unexplained hypokalemia and metabolic alkalosis, even if tests are normal otherwise.

Area of Science:

  • Pediatric Nephrology
  • Clinical Genetics
  • Neurology

Background:

  • Gitelman syndrome (GS) is a rare genetic disorder affecting ion transport in the kidneys.
  • It typically presents with hypokalemia, metabolic alkalosis, and hypomagnesemia.

Observation:

  • A 3-year-old Japanese male presented with febrile status epilepticus, exhibiting metabolic and respiratory acidosis, hypokalemia, hypomagnesemia, and elevated bicarbonate.
  • These abnormalities resolved with fluid therapy.

Findings:

  • Previous seizure clusters showed similar electrolyte and acid-base disturbances, including hypokalemia and metabolic alkalosis.
  • Genetic testing confirmed Gitelman syndrome.
  • The patient's abnormalities were primarily observed during 'sick days' or acute illness.

Implications:

  • This case underscores that Gitelman syndrome may manifest electrolyte and acid-base imbalances predominantly during acute illness.
  • Clinicians should consider GS in patients with unexplained hypokalemia and metabolic alkalosis, especially when abnormalities fluctuate.
  • Early diagnosis of GS is crucial for appropriate management and preventing complications.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
109
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
234
Pedigree Analysis01:35

Pedigree Analysis

Overview
82.1K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
529
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
233